Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Chalkstone Avenue
Prior 4
Providence, RI 02908Phone(401) 456-5312Fax(401) 456-6708- Is this information wrong?
Summary
- Dr. Steven Katz is a surgical oncologist in Providence, RI and is affiliated with Women & Infants Hospital of Rhode Island and Roger Williams Medical Center. He received his medical degree from NYU School of Medicine and has been in practice 17 years. He also speaks multiple languages, including Hebrew. He specializes in hepatobiliary surgery, melanoma, and soft tissue sarcoma. He runs a translational immunotherapy program, having led five solid tumor CAR-T clinical trials and oversees cGMP cell therapy manufacturing. Dr. Katz recently joined TriSalus Life Sciences as the Chief Medical Officer and continues to practice surgical oncology in selected indications.
Education & Training
- Memorial Sloan-Kettering2009
- NYU Grossman School of MedicineResidency, Surgery, 2007
- NYU Grossman School of MedicineInternship, Surgery, 2000 - 2001
- NYU Grossman School of MedicineClass of 2000
Certifications & Licensure
- RI State Medical License 2009 - 2022
- OH State Medical License 2008 - 2009
- NY State Medical License 2001 - 2016
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells Start of enrollment: 2011 Jun 01
- CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases Start of enrollment: 2015 Apr 01
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer Start of enrollment: 2017 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis Model.Louis F Chai, John C Hardaway, Kara R Heatherton, Kyle P O'Connell, Jason P LaPorte, Prajna Guha, Mikayla C Lopes, Benjamin A Rabinowitz, David Jaroch, Bryan F Cox, Ro...> ;The Journal of surgical research. 2022 Apr 1
- 1 citationsProteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets.Nicholas A. DaSilva, Benjamin J. Barlock, Prajna Guha, Chandra C. Ghosh, Catherine E. Trebino, Jodi L. Camberg, Steven C. Katz, David C. Rowley> ;Cell death discovery. 2021 Sep 4
- 1 citationsRegional Delivery of Anti-PD-1 Agent for Colorectal Liver Metastases Improves Therapeutic Index and Anti-Tumor Activity.Louis F. Chai, John C. Hardaway, Kara R. Heatherton, Kyle O’Connell, Mikayla C. Lopes, Benjamin A. Rabinowitz, Chandra C. Ghosh, Prajna Guha, David Benjamin Jaroch, Br...> ;Vaccine. 2021 Jul 21
- Join now to see all
Journal Articles
- STAT3 Inhibition Induces Bax-Dependent Apoptosis in Liver Tumor Myeloid-Derived Suppressor CellsGeorge Miller, N Joseph Espat, Steven C Katz, Nature
Press Mentions
- High-Pressure Application Breakthrough Aids RWMC’s Immunotherapy AmbitionsDecember 21st, 2018
- TriSalus Hires Katz to Run Studies of Ex-Dynavax Cancer DrugOctober 7th, 2020
Professional Memberships
- Member
- Member
- Society of Immunotherapy for CancerMember
- Member
- Society of University SurgeonsMember
- Member
Other Languages
- Hebrew
Hospital Affiliations
- Women & Infants Hospital of Rhode IslandProvidence, Rhode Island
- Roger Williams Medical CenterProvidence, Rhode Island
External Links
- Roger Williams Surgical Oncology http://www.rhodeislandcancer.org
- RWMC Clinical Trialshttp://www.rhodeislandcancer.org/Services/ClinicalTrials/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: